Hemodynamic alterations in cirrhosis and portal hypertension.
about
Pathophysiology of portal hypertensionSevere portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.ANG II receptor subtype 1a gene knockdown in the subfornical organ prevents increased drinking behavior in bile duct-ligated ratsSodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study.Mesenteric and splenic contributions to portal venous CT perfusion in hepatic diffuse disease.Penicillar arterioles of red pulp in residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients: a comparative study.Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver CirrhosisAST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis.Intracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile-duct-ligated rats.Tissue mechanics and fibrosis.Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease.Effect of portal vein ligation on tumor growth and liver regeneration in rat cirrhotic liver lobes.The role of chemokines in acute and chronic hepatitis C infection.Laparoscopic versus open splenectomy for portal hypertension: a systematic review of comparative studies.Review article: the endocannabinoid system in liver disease, a potential therapeutic target.Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis.Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats.Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis.Renin angiotensin system in liver diseases: Friend or foe?Glutamine prevents oxidative stress in a model of portal hypertensionMesenteric artery responsiveness to acetylcholine and phenylephrine in cirrhotic rats challenged with endotoxin: the role of TLR4.Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison.Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage.Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension.Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.B-cell-associated immune profiles in patients with decompensated cirrhosis.A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.Liver and systemic hemodynamics in children with cirrhosis: Impact on the surgical management in pediatric living donor liver transplantation.Dysregulated apoptosis of the venous wall in chronic venous disease and portal hypertension.Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experimentsPPARα activation in portal hypertension
P2860
Q27026406-40A67750-8D84-47A0-B3B7-1601EFABBA51Q30414993-100977C3-85EB-4A11-B131-76C669892485Q30741669-7CB3D631-CF5D-4531-AE47-4FED61F65D37Q34201130-9E7593FD-39A3-496D-9D47-8C01180B8010Q34350388-C0012097-7FAF-43A2-B92E-28289706A34DQ34733162-F39D84F5-2D6E-47EB-85EC-3133E2B3E3A8Q35144976-28663D52-56EE-41BD-A7E2-9EBD532F1834Q35472862-D20C5EF4-E9E3-4B0E-B687-CBE85C5CD79CQ36153972-56AD4F72-D23D-4F06-B1EC-3CA9BD4AC87CQ36412910-685EE7E8-DF2C-4677-BEC0-56D64FCAEAD1Q36664042-AE15B924-87C6-4C6D-A4CA-9826C4E8E13EQ36711459-0D4C6CF9-4277-4E25-BE4F-E5C0F0CB4B09Q36809075-8B3CFCB2-8634-46FF-8CB3-23F07126F56EQ37622223-F69581BF-D974-411E-BFB8-E9DB4E1D772BQ37709984-69886F8A-5D0F-4AAD-9F6F-879935CC28CAQ38129709-1A326781-0CF0-4A06-9168-E4AF9605E575Q38185242-688F45F0-1DD9-4D4C-AB83-403649F662EEQ38194626-869BAA73-D9F4-4F6C-A78C-CC0F30332040Q38383495-C194F375-BCEC-4FBE-ACD5-8ABF3C03B73DQ38469128-CD9A3494-3EC0-453A-9A44-4AA7F493267AQ38708565-F29AC6A0-7E83-413E-9D2E-2CE75233C9E4Q38905396-B8DD1291-D12F-4148-AEB8-75FFE59FAA91Q39198097-DE691DDD-A22D-4A55-B6FC-87D0C75A62D0Q39360840-FBE905A3-BB39-46C7-AE65-9CA6C406E91CQ40976036-900D1988-BB67-4EB0-96A5-BA5663EDA6ACQ41227808-526A660E-3E1B-4F6D-B59D-DAB1500C058EQ44899872-3DDD54A3-A3F5-4D66-9075-284C4E007143Q45734844-4380C778-F4DF-4267-B8B6-F1E40B36E26FQ48119594-CCAE545F-8E27-4688-B690-6F03D3B93B1EQ48155342-18694FC2-FBFA-4B53-BAA8-A8CD1E9E4003Q50741919-94DE0169-A88D-4ADD-82BB-B6C4D0D39772Q51501472-1DDCDE9C-043E-4E2F-A1DF-4160856A93B5Q51823738-FCD7C1F1-CD8D-467E-8967-444D4A889530Q52911498-0019FF29-60DA-4B9C-913D-D881B5F5A4FAQ57115035-AFA4675E-E636-4460-AFCA-AECA06AE6384Q58308608-E1680944-EA8B-40FE-9AB4-60847F260230
P2860
Hemodynamic alterations in cirrhosis and portal hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hemodynamic alterations in cirrhosis and portal hypertension.
@en
Hemodynamic alterations in cirrhosis and portal hypertension.
@nl
type
label
Hemodynamic alterations in cirrhosis and portal hypertension.
@en
Hemodynamic alterations in cirrhosis and portal hypertension.
@nl
prefLabel
Hemodynamic alterations in cirrhosis and portal hypertension.
@en
Hemodynamic alterations in cirrhosis and portal hypertension.
@nl
P2093
P2860
P921
P1476
Hemodynamic alterations in cirrhosis and portal hypertension.
@en
P2093
Moon Young Kim
Samuel S Lee
Soon Koo Baik
P2860
P304
P356
10.3350/KJHEP.2010.16.4.347
P5008
P577
2010-12-01T00:00:00Z